NEWS
In a highly interactive format, key opinion leaders will identify and discuss policies and programs that could facilitate the adoption high value personalized medicine technologies, while at the same time avoiding adoption of low value technologies.
Internationally renowned leaders in personalized medicine and health economics will present research and commentary on the most pressing needs at the intersection of these two disciplines.
Topic being addressed:
- HTA in Cancer and Cancer Diagnostics
- Value of Information and Early Assessment Methods for Cancer Diagnostics
- Ethical Considerations in Application of Personalized Medicine Strategies
- Coverage with Evidence Development
- Models for Conditional Coverage
- Clinical Applications of Molecular Diagnostics in Cancer: Case Studies of Mammaprint and KRAS
Who should attend ?
- Clinical and laboratory-based researchers with interest in personalized medicine
- Pharma/device developers working in technologies tied to personalized medicine
- HTA professionals interested in the application of HTA methodologies to personalized medicine and oncology
- Clinical Oncologists interested in tailored therapies
- Health system leaders
- Government and policy leaders
Registration and program on www.health-economics.lu
An information meeting about the new programme and possibilities to participate will take place on 10.5.2012 at 18.30 in the Amphitheater of the CHL in Luxembourg. More information to be found in the attachment (
He further investigated the mechanism by which the virus acquires high levels of antiviral resistance and especially how the virus adapts to the new constraints imposed by this new class of antiretroviral drugs. In order to measure resistance and fitness levels of viruses isolated from clinical samples he developed two recombinant viral assays.
Since 2010 Franky Baatz is a researcher at Complix Luxembourg SA. This biopharmaceutical company is engaged in the discovery and development of Alphabodies, which can bind with high affinity and selectivity to a wide range of disease targets, due to a stability approaching that of small chemicals and the specificity of antibodies. Previously, he has graduated from Université Libre de Bruxelles (ULB) with a Master in Biomedical Sciences.
To celebrate and promote Clinical Research, the Clinical and Epidemiological Investigation center will organize an International Clinical Trials’ Day (ICTD) in Luxembourg. The main goal will be to highlight the importance of Clinical Research, both to the public and to healthcare professionals.
The Clinical and Epidemiological Investigation Center of CRP-Santé, in collaboration with ECRIN, will be represented in various hospitals in Luxembourg. Researchers of the CIEC will be providing visitors with insightful information on its research projects as well as methods and current issues of Clinical Research.
This register will gather information allowing to support the National health policy, especially the cancer plan. It will also provide statistics and indicators to the professionals allowing them to analyze the care offered to patients suffering from cancer in Luxembourg.
Contact: marie-lise.lair@crp-sante.lu and sophie.couffignal@crp-sante.lu
This course is based on Stephen Senn's well-known book, which has been universally recognised as a comprehensive, thought-provoking and readable guide. No punches are pulled and important issues will be frankly discussed whether they concern matters on which there is general consensus or those that attract controversy.
Mathematical detail will be avoided but the value of statistics as a form of advanced common sense and a guide to rational decision-making will be stressed. The emphasis will be on practical philosophy rather than abstract algebra.
Details and online registration on: www.Statistical-Issues.lu